Morse CyberKnife CEO James G. Schwade, M.D. Announces Non-Surgical Treatment With CyberKnife Radiosurgery for Prostate Cancer
Morse CyberKnife CEO, James G. Schwade, M.D., says, "for many cases thatare diagnosed early on, CyberKnife radiosurgery may be highly effectivewithout invasive, debilitating surgery or long courses of radiation."
CyberKnife is image guided robotic radiosurgery that precisely targets alesion or tumor and delivers an intense dose of radiation to a very small areakilling the cancer cells within.
It is the mission of the Morse CyberKnife Centers to make the technologyan option available to all cancer patients who might benefit. For moreinformation please visit www.morsecyberknife.com or call 1-800-279-2900.The CyberKnife treats prostate cancer in the following manner: -- Outpatient status -- Non-invasive -- Less pain and side effect than most alternatives -- Complete treatment in 3-5 visits, each usually no longer than 1.5 hrs -- Minimum radiation to surrounding normal areas
SOURCE Morse CyberKnife
You May Also Like